White Paper

Technology Selection For Bioavailability Enhancement

Source: Lonza Pharma & Biotech

By David K. Lyon, Ph.D., Senior Fellow, Research

Lonza_Image_SDD.png

The increasing prevalence in pharmaceutical pipelines of active compounds with low solubility has led to the proliferation of approaches to increase oral drug absorption and bioavailability. Selection of the proper technology can make the difference between development success or failure.

Careful selection of the right technology to enhance bioavailability and oral drug absorption is essential in development programs from initial preclinical phases to commercialization. A science-based technology selection process is presented, based on a series of inputs including the target product profile, drug properties, extensive past project experiences, technology maps, and absorption modeling.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: